Earnings summaries and quarterly performance for CHURCH & DWIGHT CO INC /DE/.
Executive leadership at CHURCH & DWIGHT CO INC /DE/.
Richard Dierker
Detailed
President and Chief Executive Officer
CEO
BB
Brian Buchert
Detailed
Executive Vice President of Strategy, M&A and Business Partnerships
CH
Carlen Hooker
Detailed
Executive Vice President, Chief Commercial Officer
CL
Carlos Linares
Detailed
Executive Vice President, Chief Technology Officer & Global New Product Innovation
CR
Carlos Ruiz Rabago
Detailed
Executive Vice President, Chief Supply Chain Officer
JL
Joseph Longo
Detailed
Vice President, Controller and Chief Accounting Officer
KG
Kevin Gokey
Detailed
Executive Vice President, Chief Information Officer
LM
Lee McChesney
Detailed
Executive Vice President, Chief Financial Officer
MR
Michael Read
Detailed
Executive Vice President, International
Pd
Patrick de Maynadier
Detailed
Executive Vice President, General Counsel and Secretary
RH
Rene Hemsey
Detailed
Executive Vice President, Chief Human Resources Officer
SP
Surabhi Pokhriyal
Detailed
Executive Vice President, Chief Digital Growth Officer
Board of directors at CHURCH & DWIGHT CO INC /DE/.
AW
Arthur Winkleblack
Detailed
Director
BC
Bradlen Cashaw
Detailed
Director
BI
Bradley Irwin
Detailed
Director
JV
Janet Vergis
Detailed
Director
LY
Laurie Yoler
Detailed
Director
MS
Michael Smith
Detailed
Director
PP
Penry Price
Detailed
Director
RS
Ravichandra Saligram
Detailed
Chair of the Board
RS
Robert Shearer
Detailed
Director
SS
Susan Saideman
Detailed
Director
Research analysts who have asked questions during CHURCH & DWIGHT CO INC /DE/ earnings calls.
AT
Andrea Teixeira
JPMorgan Chase & Co.
6 questions for CHD
Also covers: CELH, CENT, CL +20 more
Anna Lizzul
Bank of America Corporation
6 questions for CHD
Also covers: CLX, COTY, ELF +3 more
RP
Rupesh Parikh
Oppenheimer & Co. Inc.
6 questions for CHD
Also covers: ACI, BJ, CHWY +16 more
Bonnie Herzog
Goldman Sachs
5 questions for CHD
Also covers: CASY, CCEP, CELH +21 more
Filippo Falorni
Citigroup Inc.
5 questions for CHD
Also covers: CELH, CL, CLX +12 more
Christopher Carey
Wells Fargo & Company
4 questions for CHD
Also covers: CAG, CL, CLX +21 more
DM
Dara Mohsenian
Morgan Stanley
4 questions for CHD
Also covers: CL, CLX, EL +12 more
Kevin Grundy
BNP Paribas
4 questions for CHD
Also covers: CELH, CL, CLX +8 more
LL
Lauren Lieberman
Barclays
4 questions for CHD
Also covers: CCEP, CL, CLX +18 more
OT
Olivia Tong Cheang
Raymond James Financial, Inc.
4 questions for CHD
Also covers: BBWI, CL, CLX +13 more
PG
Peter Grom
UBS Group
4 questions for CHD
Also covers: BRBR, CELH, CL +25 more
JE
Javier Escalante Manzo
Evercore ISI
3 questions for CHD
Also covers: CLX, KMB, KVUE +2 more
Robert Moskow
TD Cowen
3 questions for CHD
Also covers: BGS, BRBR, BYND +27 more
Stephen Robert Powers
Deutsche Bank
3 questions for CHD
Also covers: BRBR, CL, CLX +20 more
Chris Carey
Wells Fargo Securities
2 questions for CHD
Also covers: CAG, CL, CLX +13 more
NM
Nik Modi
RBC Capital Markets
2 questions for CHD
Also covers: CL, KDP, KMB +8 more
OT
Olivia Tong
Raymond James
2 questions for CHD
Also covers: BBWI, CL, EPC +3 more
JA
Jefferies Analyst
Jefferies Financial Group Inc.
1 question for CHD
Also covers: AOS
KW
Karen Wolfe
Piper Sandler
1 question for CHD
Kaumil Gajrawala
Jefferies
1 question for CHD
Also covers: BARK, BRBR, BTMD +22 more
KW
Korinne Wolfmeyer
Piper Sandler & Co.
1 question for CHD
Also covers: AIRS, BBWI, CL +14 more
MA
Mark Astrachan
Stifel
1 question for CHD
Also covers: ARKO, CELH, CL +7 more
PG
Philip Gorham
Citi
1 question for CHD
Steve Powers
Deutsche Bank
1 question for CHD
Also covers: BRBR, CL, CLX +22 more
William Chappell
Truist Securities
1 question for CHD
Also covers: BRBR, BRCC, CENT +9 more
Recent press releases and 8-K filings for CHD.
Church & Dwight reports Q4 2025 results and 2026 growth plan
CHD
Earnings
Guidance Update
M&A
- In 2025 CHD grew faster than its categories across all three divisions, gained share in 4 of 8 power brands, and closed strategic acquisitions including Touchland.
- The company ended FY 2025 as a $6.2 billion enterprise (77% domestic, 18% international, 5% SPD) with 1.5× leverage, over $5 billion in liquidity, and announced a 4.2% dividend increase.
- For 2026 CHD targets 3% US organic growth, aiming to expand Arm & Hammer from $2 billion to $3 billion, TheraBreath from $1 billion to $1.5 billion, and double international sales to $2 billion.
- Innovation drives ~50% of growth with 1.5–2% incremental net sales targets, while e-commerce has risen from 2% to 24% of sales via omni-channel and AI initiatives.
4 days ago
Church & Dwight reports Q4 2025 results and 2026 guidance
CHD
Earnings
Guidance Update
Dividends
- Q4 sales of $1.6 billion were up 3.9%, with organic growth of 0.7% (1.8% ex-VMS), gross margin +90 bps, and EPS of $0.86, +12% YoY.
- Full-year 2025 organic sales grew 0.7% (2.0% ex-VMS), with record cash flow of $1.2 billion and tariff exposure cut from $190 million to $25 million.
- 2026 guidance: 3–4% organic growth, reported sales down 1.5–0.5% (portfolio exits), gross margin +100 bps, EPS +5–8%, and FCF of $1.15 billion.
- Shareholder returns include a 4.2% dividend increase (125th consecutive year) and continued share buybacks, with leverage at 1.5× EBITDA.
4 days ago
Church & Dwight reports Q4 2025 results and 2026 guidance
CHD
Earnings
Guidance Update
Product Launch
- Q4 2025 sales rose 3.9%, with organic growth of 0.7% (or 1.8% ex-VMS), gross margin up 90 bps, and EPS of $0.86, +12% y/y.
- FY 2025 highlights: $6.2 billion in revenue, 0.7% organic growth (2% ex-VMS), $1.2 billion in free cash flow, 1.5x leverage, and a 4.2% dividend increase for 2026.
- 2026 guidance: organic growth of 3–4%, reported sales down 1.5 to 0.5% (due to divestitures), +100 bps in gross margin, marketing spend at 11%, EPS growth of 5–8%, and $1.15 billion in free cash flow.
- Strategic priorities include expanding Arm & Hammer from $2 billion to $3 billion via a Good-Better-Best portfolio, targeting #1 share in mouthwash and launching TheraBreath toothpaste, sustaining 1.5–2% incremental net-sales growth from innovation, and doubling down on international M&A.
4 days ago
Church & Dwight reports Q4 2025 results and 2026 outlook
CHD
Earnings
Guidance Update
Dividends
- Q4 2025 net sales of $1,644.2 M (+3.9% YoY; organic +0.7%), adjusted gross margin of 45.5%, adjusted EPS of $0.86 (+11.7%), and cash from operations of $363.4 M.
- FY 2025 net sales of $6,203.2 M (+1.6%; organic +0.7%), adjusted EPS of $3.53 (+2.6%), cash from operations of $1.215 B, and a 4% dividend increase to $1.18 per share.
- 2026 outlook: organic sales growth of 3–4%, adjusted EPS growth of 5–8%, and operating cash flow of $1.15 B, with capex around $130 M.
4 days ago
Church & Dwight reports Q4 & full-year 2025 results and issues 2026 outlook
CHD
Earnings
Guidance Update
- Q4 net sales rose 3.9% to $1,644.2 M, with organic sales up 0.7%, adjusted EPS of $0.86 (+11.7%), and cash from operations of $363.4 M
- Full-year 2025 net sales grew 1.6% to $6,203.2 M; adjusted EPS reached $3.53 (+2.6%), and operating cash flow was $1.215 B (+5.1%)
- 2026 outlook targets 3–4% organic sales growth, a 1.5% to 0.5% reported sales decline (exit impact), 100 bps gross margin expansion, and 5–8% adjusted EPS growth
- Q1 2026 guidance projects adjusted EPS of $0.92 per share, with organic sales growth of ~3%
4 days ago
Church & Dwight to sell VitaFusion and L’il Critters brands
CHD
M&A
- On December 9, 2025, Church & Dwight announced a definitive agreement to sell its VitaFusion® and L’il Critters® brands, including related trademarks and manufacturing and distribution facilities in Vancouver and Ridgefield, WA, to Piping Rock Health Products, Inc.
- The transaction is subject to customary closing conditions and is expected to close before the end of 2025.
- The VMS brands represent less than 5% of Church & Dwight’s anticipated 2025 net sales.
- Church & Dwight expects to incur a one-time, after-tax charge of $40–45 million in Q4 2025, net of proceeds, impairment, and transaction costs.
- This divestiture will enable Church & Dwight to focus on its core power brands, strengthening its portfolio and growth initiatives.
Dec 9, 2025, 9:45 PM
Church & Dwight to divest VitaFusion and L’il Critters brands
CHD
M&A
- Church & Dwight has entered a definitive agreement to sell the VitaFusion and L’il Critters brands to Piping Rock Health Products, including relevant trademarks, licenses and the Vancouver and Ridgefield manufacturing and distribution facilities.
- The transaction, subject to customary closing conditions, is expected to close before the end of 2025.
- These VMS brands account for less than 5% of the company's anticipated 2025 net sales, and the company expects a one-time, after-tax charge of $40–45 million in Q4 2025 for non-cash impairment and transition and transaction costs.
- The divestiture is aimed at strengthening focus on Church & Dwight’s remaining power brands to drive market-leading performance and growth initiatives.
Dec 9, 2025, 9:30 PM
Church & Dwight reports Q3 2025 results
CHD
Earnings
Guidance Update
M&A
- Organic sales rose 3.4% (volumes +4%, price/mix -0.6%) and reported revenue increased 5% in Q3, driven by strong brand performance and the Touchland acquisition.
- Adjusted EPS was $0.81 (up 2.5% YoY; $0.09 above guidance) and adjusted gross margin reached 45.1% (up 10 bps YoY; 110 bps above outlook).
- July’s acquisition of Touchland—the #2 U.S. hand sanitizer brand with ~7% household penetration—has outperformed initial expectations in Q3.
- Full-year guidance was raised: reported sales growth to ~1.5%, organic growth to ~1%, and adjusted EPS to $3.49 (+$0.02); marketing spend now expected to exceed 11% of net sales.
- Operating cash flow climbed 19.6% to $435.5 million, and the company repurchased $300 million of shares in Q3 (totaling $600 million YTD).
Oct 31, 2025, 2:00 PM
Church & Dwight reports Q3 2025 results
CHD
Earnings
Guidance Update
Share Buyback
- Organic sales grew 3.4% in Q3, and adjusted EPS was $0.81 versus a $0.72 outlook
- Adjusted gross margin reached 45.1%, up 10 bps year-over-year; full-year gross margin now expected to contract only 40 bps versus 2024
- Operating cash flow rose 19.6% to $435.5 million, and $600 million of shares repurchased year-to-date
- Touchland acquisition outperformed initial projections; international organic sales increased 8.4%
- 2025 outlook maintained: organic sales growth of ~1%, adjusted EPS raised to $3.49 (up $0.02), with marketing spend to exceed 11% of sales
Oct 31, 2025, 2:00 PM
Church & Dwight reports Q3 2025 results
CHD
Earnings
Guidance Update
Share Buyback
- Organic sales grew 3.4% and adjusted EPS was $0.81, both exceeding outlook; adjusted gross margin improved 10 bps to 45.1%.
- Acquisition of Touchland closed in July; brand is now #2 in U.S. hand sanitizer with ~7% household penetration and delivered double-digit consumption growth in Q3.
- U.S. Consumer segment: organic sales +2.3% (volume +3.7%, price/mix -1.4%); key brands Arm & Hammer, TheraBreath, and Hero expanded share and penetration.
- Full-year outlook raised: organic growth ~1%, adjusted EPS $3.49 (+$0.02) and Q4 adjusted EPS $0.83 (+8% YoY) with reported sales growth ~3.5%.
- Cash from operations was $435.5 M (+19.6% YoY); the company repurchased $300 M of shares in Q3, totaling $600 M YTD.
Oct 31, 2025, 2:00 PM
Quarterly earnings call transcripts for CHURCH & DWIGHT CO INC /DE/.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more